Concepedia

Shukkwan Kelly Lau

SK

2

Publications

38

Citations

2

H-Index

2021

Active since

Affiliations

Biogen (United States)(Current)

Shukkwan Kelly Lau is an author at Biogen (United States) specializing in in vivo gene therapy, neurodegenerative diseases, and genome engineering.

Top concepts

Publications per year

2021–2022

2

Publications

2

In vivo genome editing using novel AAV-PHP variants rescues motor function deficits and extends survival in a SOD1-ALS mouse model

Yi A. Chen, Mark W. Kankel, Sam Hana et al. · Gene Therapy · 2022 · 25 citations · Full text

, , +10

Development of a one-step RT-ddPCR method to determine the expression and potency of AAV vectors

Pete Clarner, Shukkwan Kelly Lau, Twinkle Chowdhury et al. · Molecular Therapy — Methods & Clinical Development · 2021 · 13 citations · Full text

Rows per page

1–2 of 2